• About Cancer Council’s Clinical Practice Guidelines
• Adolescents and young adults (AYA) cancer clinical guidelines
  • Early detection of cancer in AYAs
  • Psychosocial management of AYAs diagnosed with cancer: Guidance for health professionals
• Archive of clinical guidelines and resources
• Bowel cancer clinical guidelines
  • Clinical practice guidelines for the prevention, early detection and management of colorectal cancer
  • Clinical practice guidelines for surveillance colonoscopy
• COSA guidelines for fertility preservation for people with cancer
  • Appendices
    • Additional resources
    • Guideline development process
    • COSA Fertility Preservation Guidelines Working Group
  • Conception
    • Assisted reproduction and risk of cancer recurrence
    • Interrupting hormone therapy to conceive
  • Contraception
    • Contraception after cancer treatment
    • Cancer Fertility Preservation
  • Discussing Risk
    • Health professional awareness
    • Reproductive concerns
    • Role of oncology services
  • Impact on fertility
    • Ovarian function
    • Pregnancy and live birth
    • Testicular function
  • Pubertal development
  • Options for treatment
    • Embryo cryopreservation
    • Oocyte cryopreservation
    • Safety of ovarian stimulation
    • Ovarian suppression with GnRH analogues
    • Ovarian tissue cryopreservation
    • Ovarian transposition
    • Sperm cryopreservation
    • Testicular biopsy
  • Pregnancy
    • Pregnancy and risk of cancer recurrence
    • Risk of pregnancy complications
  • Psychological support
    • Decision making
    • Fertility counselling
  • Referral and service provision
    • Referral rates and decisional conflict
    • Oncofertility service provision
    • Referral pathways
  • Summary of recommendations
• Cancer pain management in adults clinical guidelines
• COSA guidelines for the safe prescribing, dispensing and administration of systemic cancer therapy
• Cervical cancer clinical guidelines
  • National cervical screening program
    • Appendices
      • Appendix C
      • Appendix G
      • Appendix I
      • Appendix B
      • Appendix A
      • Appendix F
      • Appendix J
      • Appendix H
      • Appendix D
      • Appendix E
    • 5. Benefits, harms and cost-effectiveness in renewed National Cervical Screening Program (NCSP)
    • 1. Cervical cancer in Australia
    • 7. Colposcopy
      • Colposcopy data for the National Cancer Screening Register
      • Supplement. Colposcopy information for discussion with patient
      • Supplement. Colposcopy technologies and documentation
      • Colposcopy terminology
      • History, examination and investigation
      • Principles of practice
      • Quality improvement in colposcopy
      • Colposcopy and treatment
    • Foreword
    • 12. HPV screening strategies for Aboriginal and Torres Strait Islander women
    • Introduction
    • Cervical Cancer Screening Guideline July 2022 Updates - PDFs
    • 8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
      • Management of discordant colposcopic impression, histopathology and referral LBC prediction
      • Normal colposcopic findings following LBC prediction of Negative, LSIL or HSIL
      • Type 3 TZ (previously termed ‘unsatisfactory’) colposcopy following LBC prediction of Negative, LSIL or HSIL
    • 10. Management of histologically confirmed high-grade squamous abnormalities
      • Diagnosis of high-grade squamous abnormalities
      • Management of histologically confirmed high-grade squamous abnormalities
      • Test of Cure after treatment for HSIL (CIN2/3)
      • Treatment of high-grade squamous abnormalities
    • 11. Management of glandular abnormalities
      • Follow-up after excisional treatment for AIS
      • Investigation of cytological glandular abnormalities
      • Management of histologically confirmed high-grade glandular abnormalities
    • 9. Management of histologically confirmed low-grade squamous abnormalities
    • 6. Management of oncogenic HPV test results
      • Flowcharts: Management of oncogenic HPV test results
      • Management of HPV test results
      • Medical Services Advisory Committee recommendations for HPV testing
      • Oncogenic HPV types 16 and/or 18
      • Oncogenic HPV types not 16/18
      • Oncogenic HPV types not detected
      • Screening in women older than 75
      • Self-collected vaginal samples
      • Women undergoing exit testing
    • 19. Psychosocial care
    • 13. Screening after total hysterectomy
    • 17. DES-exposed women
    • 16. Screening in immune-deficient women
    • 14. Screening in pregnancy
    • 18. Signs and symptoms of cervical cancer
      • Investigation of abnormal vaginal bleeding
      • Investigations of other symptoms: vaginal discharge and deep dyspareunia
    • Summary of recommendations
    • 3. Terminology
      • Cytology and AMBS 2004 terminology for reporting
      • Histopathology
      • HPV testing terminology
      • Preparation of cervical screening reports
      • Supplement: Sample reports
    • 2. The rationale for primary HPV screening
    • 20. Transition to the renewed National Cervical Screening Program
    • 4. Unsatisfactory cervical screening results
    • 15. Women experienced early sexual activity or victims of abuse
• Clinical practice guideline for the management of communication and swallowing in children diagnosed with childhood brain tumour or leukaemia
• A code of practice for declaring and dealing with competing interests
• Clinical practice guidelines for the treatment and management of endometrial cancer
• Browse all clinical guidelines
  • Early detection of cancer in AYA
• Evidence-based practice guidelines for the nutritional management of adult patients with head and neck cancer
• Liver cancer clinical guidelines
  • Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia (Coming soon)
• Lung cancer clinical guidelines
  • Clinical practice guidelines for the prevention and diagnosis of lung cancer
  • Clinical practice guidelines for the treatment of lung cancer
• Neuroendocrine neoplasms (NENs) clinical guidelines
  • Neuroendocrine neoplasms (NENs) clinical guidelines
• Oesophageal cancer clinical guidelines
  • Clinical practice guidelines for the diagnosis and management of Barrett’s oesophagus and early oesophageal adenocarcinoma
• Prostate cancer clinical guidelines
  • Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer
• Skin cancer clinical guidelines
  • Clinical practice guidelines for keratinocyte cancer
  • Clinical practice guidelines for the diagnosis and management of melanoma
• Clinical practice guidelines for teleoncology